These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 29864685)

  • 61. Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies.
    Abdel-Aziz AA; El-Azab AS; Abou-Zeid LA; ElTahir KE; Abdel-Aziz NI; Ayyad RR; Al-Obaid AM
    Eur J Med Chem; 2016 Jun; 115():121-31. PubMed ID: 26999325
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel 1,3,4-oxadiazole/oxime hybrids: Synthesis, docking studies and investigation of anti-inflammatory, ulcerogenic liability and analgesic activities.
    Abd-Ellah HS; Abdel-Aziz M; Shoman ME; Beshr EA; Kaoud TS; Ahmed AF
    Bioorg Chem; 2016 Dec; 69():48-63. PubMed ID: 27669120
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design, Synthesis, and Biological Evaluation of Some Novel Pyrrolizine Derivatives as COX Inhibitors with Anti-Inflammatory/Analgesic Activities and Low Ulcerogenic Liability.
    Gouda AM; Ali HI; Almalki WH; Azim MA; Abourehab MA; Abdelazeem AH
    Molecules; 2016 Feb; 21(2):. PubMed ID: 26867188
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis and biological evaluation of pyrazolone analogues as potential anti-inflammatory agents targeting cyclooxygenases and 5-lipoxygenase.
    Shabaan MA; Kamal AM; Faggal SI; Elsahar AE; Mohamed KO
    Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900308. PubMed ID: 32031284
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors.
    Eleftheriou P; Geronikaki A; Hadjipavlou-Litina D; Vicini P; Filz O; Filimonov D; Poroikov V; Chaudhaery SS; Roy KK; Saxena AK
    Eur J Med Chem; 2012 Jan; 47(1):111-24. PubMed ID: 22119153
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New Substituted 5-Benzylideno-2-Adamantylthiazol[3,2-b][1,2,4]Triazol-6(5
    Tratrat C; Haroun M; Paparisva A; Kamoutsis C; Petrou A; Gavalas A; Eleftheriou P; Geronikaki A; Venugopala KN; Kochkar H; Nair AB
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33513963
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Discovery of potential anti-inflammatory drugs: diaryl-1,2,4-triazoles bearing N-hydroxyurea moiety as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase.
    Jiang B; Huang X; Yao H; Jiang J; Wu X; Jiang S; Wang Q; Lu T; Xu J
    Org Biomol Chem; 2014 Apr; 12(13):2114-27. PubMed ID: 24562695
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthesis of new multitarget-directed ligands containing thienopyrimidine nucleus for inhibition of 15-lipoxygenase, cyclooxygenases, and pro-inflammatory cytokines.
    Abdelkhalek AS; Kothayer H; Rezq S; Orabi KY; Romero DG; El-Sabbagh OI
    Eur J Med Chem; 2023 Aug; 256():115443. PubMed ID: 37182334
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel 5,6-diphenyl-1,2,4-triazine-3-thiol derivatives as dual COX-2/5-LOX inhibitors devoid of cardiotoxicity.
    Saraf P; Nath Tripathi P; Kumar Tripathi M; Tripathi A; Verma H; Kumar Waiker D; Singh R; Kumar Shrivastava S
    Bioorg Chem; 2022 Dec; 129():106147. PubMed ID: 36126607
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Marginally designed new profen analogues have the potential to inhibit cyclooxygenase enzymes.
    Gülcan HO; Ünlü S; Dimoglo A; Şahin Y; Esiringu İ; Erçetin T; Öz D; Şahin MF
    Arch Pharm (Weinheim); 2015 Jan; 348(1):55-61. PubMed ID: 25581679
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Celastrol modulates inflammation through inhibition of the catalytic activity of mediators of arachidonic acid pathway: Secretory phospholipase A
    Joshi V; Venkatesha SH; Ramakrishnan C; Nanjaraj Urs AN; Hiremath V; Moudgil KD; Velmurugan D; Vishwanath BS
    Pharmacol Res; 2016 Nov; 113(Pt A):265-275. PubMed ID: 27597642
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Design, synthesis and molecular docking of benzophenone conjugated with oxadiazole sulphur bridge pyrazole pharmacophores as anti inflammatory and analgesic agents.
    Zabiulla ; Gulnaz AR; Mohammed YHE; Khanum SA
    Bioorg Chem; 2019 Nov; 92():103220. PubMed ID: 31493708
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors.
    Reddy MV; Billa VK; Pallela VR; Mallireddigari MR; Boominathan R; Gabriel JL; Reddy EP
    Bioorg Med Chem; 2008 Apr; 16(7):3907-16. PubMed ID: 18272371
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
    Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6138-41. PubMed ID: 18945614
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives.
    Srivastava P; Vyas VK; Variya B; Patel P; Qureshi G; Ghate M
    Bioorg Chem; 2016 Aug; 67():130-8. PubMed ID: 27376460
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
    Khalil NA; Ahmed EM; Mohamed KO; Nissan YM; Zaitone SA
    Bioorg Med Chem; 2014 Apr; 22(7):2080-9. PubMed ID: 24631365
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
    Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
    Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The study of dual COX-2/5-LOX inhibitors by using electronic-topological approach based on data on the ligand-receptor interactions.
    Aksakal F; Shvets N; Dimoglo A
    J Mol Graph Model; 2015 Jul; 60():79-88. PubMed ID: 26117823
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential.
    Said MF; Georgey HH; Mohammed ER
    Eur J Med Chem; 2021 Nov; 224():113682. PubMed ID: 34245948
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation.
    Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E
    Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.